Novartis AG Income Tax Expense Continuing Operations
Novartis AG (NVSEF) reported Income Tax Expense Continuing Operations of $2.38 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2026-02-04
- Novartis AG income tax expense continuing operations for the quarter ending 2025-06-30 was $507.00M, a 14.79% decline year-over-year.
- Novartis AG income tax expense continuing operations for the quarter ending 2024-06-30 was $595.00M, a 47.64% increase year-over-year.
- Novartis AG income tax expense continuing operations for the quarter ending 2023-06-30 was $403.00M, a 16.14% increase year-over-year.
- Novartis AG income tax expense continuing operations for the quarter ending 2022-06-30 was $347.00M, a 43.21% decline year-over-year.
| Period end | Income Tax Expense Continuing Operations 3 month | Income Tax Expense Continuing Operations 3 month as first filed | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 6 month as first filed | Income Tax Expense Continuing Operations 12 month | Income Tax Expense Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2.38B 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $507.00M 6-K · filed 2025-07-17 | $1.30B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $1.70B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $595.00M 6-K · filed 2025-07-17 | $1.04B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $551.00M 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $403.00M 6-K · filed 2024-07-18 | $452.00M 6-K · filed 2023-07-18 | $773.00M 6-K · filed 2024-07-18 | $898.00M 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $1.13B 20-F · filed 2025-01-31 | $1.42B 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $347.00M 6-K · filed 2023-07-18 | $797.00M 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $1.63B 20-F · filed 2024-01-31 | $2.12B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $611.00M 6-K · filed 2022-07-19 | $1.00B 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $1.81B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $421.00M 6-K · filed 2021-07-21 | $869.00M 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $1.79B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $525.00M 6-K · filed 2020-07-21 | $797.00M 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $1.29B 20-F · filed 2021-01-26 | $1.22B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | $443.00M 6-K · filed 2019-07-18 | $451.00M 6-K · filed 2018-07-18 | $813.00M 6-K · filed 2019-07-18 | $832.00M 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $1.60B 20-F · filed 2020-01-29 | $1.30B 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | $336.00M 6-K · filed 2018-07-18 | $618.00M 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $1.12B 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $1.11B 6-K · filed 2018-01-24 |